Patent: 10,189,833
✉ Email this page to a colleague
Summary for Patent: 10,189,833
| Title: | Solid forms of a compound modulating kinases |
| Abstract: | Solid forms of the compound, [5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-triflu- oromethyl-pyridin-3-ylmethyl)-amine HCl salt (Compound I) and its free base, active on the receptor protein kinases c-Kit and/or c-Fms and/or Flt3, were prepared and characterized: ##STR00001## Also provided are methods of using the solid forms. |
| Inventor(s): | Ibrahim; Prabha N. (Mountain View, CA), Visor; Gary Conard (Castro Valley, CA) |
| Assignee: | Plexxikon Inc. (Berkeley, CA) |
| Application Number: | 15/725,197 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,189,833
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Astrazeneca Uk Ltd | IMFINZI | durvalumab | Injection | 761069 | 05/01/2017 | ⤷ Try a Trial | 2035-05-06 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
